Table 2.
Clinical characteristics and baseline data of patients.
| N | 67 |
| Diagnosis | |
| BD type I | 42 (62.7) |
| BD type II | 23 (34.3) |
| Schizoaffective disorder | 2 (3) |
| Age of onset, years | 24.9 ± 11.5 (8-55) |
| Duration of illness, years | 17.6 ± 11.3 (0-49) |
| First episode: depression | 40 (60.6) |
| Age first depression, years | 25.9 ± 12.1 (8-55) |
| Age first mania/hypomania, years | 28.9 ± 11.9 (8-59) |
| Lifetime psychotic features | 37 (55.2) |
| Total number of hospitalizations | |
| 0 | 9 (13.4) |
| 1-5 | 45 (67.2) |
| 6-10 | 13 (19.4) |
| Lifetime substance abuse | 30 (44.8) |
| Alcohol | 18 (26.9) |
| THC | 13 (19.4) |
| Hard drugs | 5 (7.5) |
| Baseline medication use | |
| Medication-free | 6 (9.0) |
| Lithium | 24 (35.8) |
| Valproate | 9 (13.4) |
| Carbamazepine | 3 (4.5) |
| Lamotrigine | 8 (11.9) |
| Antipsychotic | 42 (62.7) |
| Antidepressant | 31 (46.3) |
| Benzodiazepine | 24 (35.8) |
| Baseline mood episode | |
| Depression | 29 (43.3) |
| (Hypo)mania | 29 (43.3) |
| Mixed | 9 (13.4) |
Data presented as mean ± SD (range) or n (%). BD, bipolar disorder; THC, tetrahydrocannabinol.